Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study

J Allergy Clin Immunol. 2013 Oct;132(4):991-3.e1. doi: 10.1016/j.jaci.2013.04.049. Epub 2013 Jun 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Sublingual
  • Allergens / administration & dosage*
  • Allergens / immunology
  • Animals
  • Antigens, Dermatophagoides / administration & dosage
  • Antigens, Dermatophagoides / immunology
  • Arthropod Proteins / administration & dosage
  • Arthropod Proteins / immunology
  • Chemoprevention
  • Child
  • Cysteine Endopeptidases / administration & dosage
  • Cysteine Endopeptidases / immunology
  • Desensitization, Immunologic / methods*
  • Glycoproteins / administration & dosage
  • Glycoproteins / immunology
  • Humans
  • Hypersensitivity, Immediate / immunology
  • Hypersensitivity, Immediate / prevention & control*
  • Immunoglobulin E / blood
  • Immunoglobulin G / blood
  • Infant
  • Pilot Projects
  • Plant Proteins / administration & dosage
  • Plant Proteins / immunology
  • Treatment Outcome

Substances

  • Allergens
  • Antigens, Dermatophagoides
  • Arthropod Proteins
  • Glycoproteins
  • Immunoglobulin G
  • Phl p V protein, Phleum pratense
  • Plant Proteins
  • Immunoglobulin E
  • Cysteine Endopeptidases
  • Dermatophagoides farinae antigen f 1
  • Dermatophagoides pteronyssinus antigen p 1
  • Fel d 1 protein, Felis domesticus

Associated data

  • ClinicalTrials.gov/NCT00346398